Skip to content

Efficacy and safety of digestive tract mucosal protective adhesive in clinical application

Efficacy and safety of digestive tract mucosal protective adhesive in clinical application

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052935
Enrollment
Unknown
Registered
2021-11-06
Start date
2020-09-01
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric ulcer after ESD surgery

Interventions

Experimental group:After gastric ESD, the wound surface was covered with digestive tract protective adhesive
Control Group:Nil

Sponsors

First Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
23 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged from 18 to 75 years old, regardless of gender; 2. Diagnosed as early gastric cancer and gastric benign tumor and in accordance with ESD surgical indications (wound diameter is larger than 2cm); 3. Sign informed consent form voluntarily.

Exclusion criteria

Exclusion criteria: 1. Patients with active infection or severe systemic diseases; 2. Severe impairment of liver function or cardiopulmonary function; 3. Patients with coagulation or bleeding dysfunction; 4. Pregnant or lactating patients; 5. Those who have received glucocorticoid treatment within 6 weeks (excluding inhalers and eye drops); 6. Use of drugs that may affect the blood coagulation system within 1 week: such as platelet receptor antagonist abciximab, tirofiban. Clopidogrel; other anticoagulants or procoagulants; 7. Patients known to be allergic to seaweed polysaccharides and polylysine; 8. Patients who are not considered suitable for surgery with this product.

Design outcomes

Primary

MeasureTime frame
Ulcer area;Ulcer area;Ulcer area;

Countries

China

Contacts

Public ContactLyu Bin

The First Affiliated Hospital of Zhejiang Chinese Medical Universty

lvbin@medmail.com.cn+86 13906515409

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026